We further found that the frequency of the TP53 mutation was 76.3% in ESCC, which was between 66.7% and 82.7% of the frequency of the TP53 mutation in EC by NGS, as previously reported [27–30]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.